Healthcare

HCR 120 establishes the PACE Task Force to study GLP-1 medications, which are drugs used for diabetes and weight loss that have seen a massive increase in demand and cost in Louisiana. This concurrent resolution directs the task force to investigate how these drugs affect insurance premiums, accessibility for different income groups, and the long-term financial impact on both public and private insurers. The group will consist of representatives from state agencies, health plans, and medical providers, who will meet to analyze pricing differences between diabetes and weight loss uses before submitting their findings to the legislature by February 2027.

SB 194 requires Louisiana state agencies to verify the U.S. citizenship or "satisfactory immigration status" of applicants for Medicaid, SNAP, and other public benefits like housing or food assistance. If verification fails after a single reasonable opportunity period, the state must refer the applicant's information to U.S. Immigration and Customs Enforcement (ICE) and terminate benefits. The bill specifies that "satisfactory immigration status" includes lawful permanent residents, Cuban/Haitian entrants, and those under Compact of Free Association agreements. Agencies must also provide monthly reports to the Secretary of State for voter list maintenance and submit annual reports to legislators on enforcement actions. This bill directly affects individuals applying for federal or state public benefits who cannot prove citizenship or qualifying immigration status.

This bill allows terminally ill patients (with a prognosis of one year or less) in Louisiana healthcare facilities to use medical marijuana under specific conditions. It requires facilities to permit use while prohibiting smoking/vaping, documenting it in medical records, and storing it securely in locked containers. Facilities must follow state guidelines but are not required to provide recommendations or include marijuana in discharge plans. The law acknowledges federal Schedule I restrictions but mandates compliance with state rules, allowing temporary suspension if federal agencies take enforcement action against such facilities.

HB 106 prohibits child day care centers in Louisiana from providing melatonin (a nonprescription sleep aid) to children without written consent from a parent or legal guardian. The law directly affects day care centers and parents/guardians, requiring centers to obtain explicit permission before administering melatonin. Violations carry penalties of up to $1,000 in fines, six months in jail, or both. The bill specifically targets melatonin use in day care settings, not all nonprescription medications. It is currently pending before the Administration of Criminal Justice Committee.

HB 926, the "Louisiana Medical Freedom Act," prohibits public buildings, government services, and businesses from denying access or services based on an individual's vaccine status or refusal of any medical intervention (including vaccines). It bans government entities from requiring vaccinations for public building access, employment, or services, and prevents businesses from denying services or employment based on medical intervention refusal. The bill explicitly states that healthy individuals cannot be excluded from public activities during health emergencies due to declining a vaccine. This law applies broadly to all public facilities, government services, and businesses operating in Louisiana.

SB 162 modifies Louisiana's workers' compensation system by changing how disputes over medical treatment decisions are handled. It allows any party disagreeing with a medical director's decision to appeal within 45 days using LWC Form 1008. To overturn a decision, the appealing party must present "clear and convincing evidence" showing the decision violated the law, and only evidence previously reviewed by the medical director can be used in the appeal. This directly affects workers and employers in Louisiana workers' compensation cases involving medical treatment disputes. The bill focuses on streamlining the appeals process for medical treatment decisions under the existing workers' compensation framework.